Gad Soffer - Net Worth and Insider Trading
Gad Soffer Net Worth
The estimated net worth of Gad Soffer is at least $105,360 dollars as of 2024-11-05. Gad Soffer is the EVP & Chief Strategy Officer of Atara Biotherapeutics Inc and owns about 10,249 shares of Atara Biotherapeutics Inc (ATRA) stock worth over $105,360. Details can be seen in Gad Soffer's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Gad Soffer has not made any transactions after 2017-11-17 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Gad Soffer
Gad Soffer Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Gad Soffer owns 3 companies in total, including Atara Biotherapeutics Inc (ATRA) , Surrozen Inc (SRZN) , and Consonance-HFW Acquisition Corp (CHFW.U) .
Click here to see the complete history of Gad Soffer’s form 4 insider trades.
Insider Ownership Summary of Gad Soffer
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ATRA | Atara Biotherapeutics Inc | 2017-11-17 | Chief Operating Officer |
| SRZN | Surrozen Inc | 2021-08-11 | other: FORMER CHIEF EXECUTIVE OFFICER |
| CHFW.U | Consonance-HFW Acquisition Corp | 2021-08-11 | other: FORMER CHIEF EXECUTIVE OFFICER |
Gad Soffer Latest Holdings Summary
Gad Soffer currently owns a total of 1 stock. Gad Soffer owns 10,249 shares of Atara Biotherapeutics Inc (ATRA) as of November 17, 2017, with a value of $105,360.
Latest Holdings of Gad Soffer
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ATRA | Atara Biotherapeutics Inc | 2017-11-17 | 10,249 | 10.28 | 105,360 |
Holding Weightings of Gad Soffer
Gad Soffer Form 4 Trading Tracker
According to the SEC Form 4 filings, Gad Soffer has made a total of 0 transactions in Atara Biotherapeutics Inc (ATRA) over the past 5 years. The most-recent trade in Atara Biotherapeutics Inc is the sale of 280 shares on November 17, 2017, which brought Gad Soffer around $105,000.
Insider Trading History of Gad Soffer
- 1
Gad Soffer Trading Performance
Gad Soffer Ownership Network
Ownership Network List of Gad Soffer
Ownership Network Relation of Gad Soffer
Gad Soffer Owned Company Details
What does Atara Biotherapeutics Inc do?
Who are the key executives at Atara Biotherapeutics Inc?
Gad Soffer is the Chief Operating Officer of Atara Biotherapeutics Inc. Other key executives at Atara Biotherapeutics Inc include EVP & Global Head RA & Quality Jill Henrich , EVP & Chief Sci. & Tech Officer Anhco Nguyen , and SVP & CFO Eric J Hyllengren .
Atara Biotherapeutics Inc (ATRA) Insider Trades Summary
Over the past 18 months, Gad Soffer made no insider transaction in Atara Biotherapeutics Inc (ATRA). Other recent insider transactions involving Atara Biotherapeutics Inc (ATRA) include a net sale of 204,620 shares made by Pascal Touchon , a net sale of 68,971 shares made by Amar Murugan , and a net sale of 64,459 shares made by Eric J Hyllengren .
In summary, during the past 3 months, insiders sold 8,050 shares of Atara Biotherapeutics Inc (ATRA) in total and bought 0 shares, with a net sale of 8,050 shares. During the past 18 months, 27,448 shares of Atara Biotherapeutics Inc (ATRA) were sold and 32,673 shares were bought by its insiders, resulting in a net purchase of 5,225 shares.
Atara Biotherapeutics Inc (ATRA)'s detailed insider trading history can be found in Insider Trading Tracker table.
Atara Biotherapeutics Inc Insider Transactions
Gad Soffer Mailing Address
Above is the net worth, insider trading, and ownership report for Gad Soffer. You might contact Gad Soffer via mailing address: C/o Atara Biotherapeutics, Inc., 3260 Bayshore Boulevard, Brisbane Ca 94005.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
